It also uses DCs from patient's PBMCs, but in this vaccine, the agent used to load the DCs is termed as AP1903, a proprietary preparation where two ligands are joined by a chemical linker.

In ulcerative colitis, on the other hand, several probiotic formulations and especially the proprietary preparation VSL#3 (a high-concentration mixture) have been found effective as adjuvant ...